Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      FCA lays out ‘landmark’ crypto clampdown

      IG has pursued a new deal in its bid to beef up its crypto capabilities

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Enzo Maresca pays Chelsea compensation to become Manchester City manager

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • City AM Puzzles
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      A meeting with the breakfast king of Mayfair

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper

Tech

  • As The New York Times and OpenAI go to war, smaller publishers are being left behind

    February 28, 2024

    As the landmark legal battle between The New York Times and OpenAI continues, the fate of smaller publishers is being ignored.

  • AI will design drugs in the next couple of years, says Google Deepmind boss

    February 27, 2024

    The chief of Google DeepMind has said artificial intelligence (AI) could be designing drugs in clinics within the next couple of years.

  • Why Meta’s Northern Europe chief is going all in on AI

    February 27, 2024

    Derya Matras, Meta's vice president for Northern Europe, sits down with City A.M. to explain how the company is looking to harness the power of AI and why the firm still believes in the Metaverse.

  • Covid unicorn Hopin enters liquidation as it moves head office to US

    February 26, 2024

    Tech unicorn Hopin, which was once worth $7.75bn, has entered liquidation less than a year after it sold off its titular events platform.

  • Big tech faces backlash over big water consumption

    February 25, 2024

    Tech giants like Microsoft, Google, and Meta have ramped up their water usage to cool their data centres, increasingly used for AI services.

  • Apple faces major UK investor rebellion over lack of AI transparency

    February 25, 2024

    Legal & General Investment Management and Abrdn are planning to challenge Apple's AI disclosure practices at its upcoming annual meeting.

  • Odysseus Moon lander may have tipped sideways but is ‘stable’

    February 24, 2024

    Lunar lander Odysseus, which became the first privately owned spacecraft to land on the Moon, is “stable” and is likely lying on its side with its head resting against a rock. Intuitive Machines’ Nova-C Odysseus lander, a private spacecraft, touched down in the Moon’s south pole region at 11.23pm UK time on Thursday. Steve Altemus, [...]

  • US lands on moon for first time in 52 years with spacecraft the size of a red phone box

    February 23, 2024

    Intuitive Machines’s Nova-C Odysseus lander touched down on the Moon at 23.23pm UK time on Thursday.

  • London’s new tech hotspot might be south of the river

    February 22, 2024

    London's tech businesses have long clustered around Old Street and Stratford. But could the new design district in Greenwich steal the crown?

  • Tagomics: Disease diagnosis firm bags £6.7m in funding for cancer research

    February 22, 2024

    The funding round will enable Tagomics to discover new signs of cancer and advance drug development and therapy selection for patients.

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 124
  • Page 125
  • Page 126
  • Page 127
  • Page 128
  • …
  • Page 1,052
  • Next

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Lloyd’s deputy chair: The City is a club in the best sense

  • A meeting with the breakfast king of Mayfair

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited